Bayesian Capital Management, LP Intercept Pharmaceuticals, Inc. Transaction History

Bayesian Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$9.99 - $18.71 $373,626 - $699,754	37,400 New	37,400 $693,000
Q3 2019 Nov 13, 2019	SELL	$58.69 - $80.46 $317,043 - $434,644	-5,402 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$77.77 - $120.68 $31,108 - $48,272	400 Added 8.0%	5,402 $430,000
Q1 2019 May 14, 2019	BUY	$91.83 - $120.68 $459,333 - $603,641	5,002 New	5,002 $560,000
Q4 2017 Feb 12, 2018	SELL	$58.2 - $72.76 $250,260 - $312,868	-4,300 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $245,143 - $510,625	4,300	4,300 $250,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Bayesian Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Bayesian Capital Management, LP with notifications on news.